2-Methyl-5-Hydroxypyridine for API Synthesis: Polymorphic Stability & Filtration Metrics
Polymorphic Stability and Particle Size Distribution in 2-Methyl-5-hydroxypyridine for API Synthesis
In the synthesis of active pharmaceutical ingredients (APIs), the polymorphic form of intermediates like 2-Methyl-5-hydroxypyridine (also known as 5-Hydroxy-2-picoline or 6-Methyl-3-pyridinol) can significantly influence downstream processing. Our material, supplied by NINGBO INNO PHARMCHEM CO.,LTD., is consistently produced as a stable crystalline solid. Through controlled crystallization from a toluene/ethyl acetate mixture, we achieve a uniform particle size distribution (PSD) with a D50 typically in the range of 50–150 µm. This PSD is critical for ensuring reproducible dissolution rates in subsequent reaction steps. As a drop-in replacement for other commercial sources, our product matches the polymorphic form (Form I) confirmed by XRPD, eliminating the need for process revalidation. For procurement managers, this means seamless integration into existing synthetic routes without unexpected polymorph-related yield losses.
In large-scale API manufacturing, polymorphic transitions during storage or processing can lead to batch failures. Our stability studies show no conversion to other forms under ICH conditions (25°C/60% RH for 36 months). However, we advise against micronization, as mechanical stress can induce amorphous content. For further insights on avoiding catalyst poisoning in related coupling reactions, see our article on sourcing 2-methyl-5-hydroxypyridine and managing catalyst poisoning in herbicide coupling.
Impact of Hydroxyl Protonation on Recrystallization Yields and Filtration Metrics
The hydroxyl group in 2-Methyl-5-hydroxypyridine (pKa ~10.5) plays a pivotal role in recrystallization. Under acidic conditions, protonation of the pyridine nitrogen (pKa ~6.7) increases solubility, while deprotonation of the hydroxyl group in basic media can lead to salt formation. For optimal recrystallization, we recommend a solvent system of isopropanol/water (70:30 v/v) at 50°C, followed by controlled cooling to 5°C. This yields a crystalline product with a filtration resistance (α) of approximately 2.5 × 10^9 m/kg, as measured by constant pressure filtration tests. Such low resistance translates to faster filtration and washing cycles in production centrifuges or Nutsche filters, reducing cycle times by up to 30% compared to poorly optimized crystallizations.
Procurement managers should note that our product's consistent crystal habit (plate-like) minimizes filter cloth blinding, a common issue with needle-shaped crystals. This directly impacts throughput in multi-ton campaigns. For a deeper dive into how impurities affect filtration, refer to our German-language resource on Beschaffung von 2-Methyl-5-Hydroxypyridin und Katalysatorvergiftung bei der Herbizidkupplung.
Purity Grades, COA Parameters, and Batch-to-Batch Consistency for Multi-Step Synthesis
Our 2-Methyl-5-hydroxypyridine is available in two standard grades: Technical (≥98.0%) and Pharma Grade (≥99.5%). The Certificate of Analysis (COA) for each batch includes critical parameters that directly impact API synthesis:
| Parameter | Technical Grade | Pharma Grade | Test Method |
|---|---|---|---|
| Assay (GC) | ≥98.0% | ≥99.5% | GC-FID |
| Water (KF) | ≤0.5% | ≤0.1% | Karl Fischer |
| Melting Point | 165–168°C | 166–168°C | DSC |
| Residue on Ignition | ≤0.1% | ≤0.05% | USP <281> |
| Heavy Metals (as Pb) | ≤10 ppm | ≤5 ppm | ICP-MS |
| Single Impurity (GC) | ≤1.0% | ≤0.2% | GC-FID |
Batch-to-batch consistency is ensured through rigorous in-process controls. The main impurity, 2-methylpyridine, is kept below 0.1% in Pharma Grade to avoid side reactions in palladium-catalyzed couplings. For custom synthesis requirements, we can adjust specifications upon request. Please refer to the batch-specific COA for exact values.
Bulk Packaging and Handling: IBC, 210L Drums, and Stability During Transport
For industrial supply, we offer standard packaging in 25 kg fiber drums, 210L steel drums (net weight 200 kg), and 1000L IBCs (net weight 800 kg). All packaging is UN-approved and complies with IMDG/ADR regulations for solid chemicals. The material is classified as non-hazardous for transport, but we recommend storage at 15–25°C in a dry, well-ventilated area. During transport, especially in tropical climates, the product may be exposed to temperature fluctuations. Our stability data confirm no degradation or caking after 14 days at 40°C/75% RH in sealed original packaging. However, we advise against using polyethylene liners for long-term storage due to potential static charge buildup, which can affect powder flow.
Field Experience: Non-Standard Parameters and Edge-Case Behavior in Large-Scale Reactors
In our experience with multi-ton API campaigns, one non-standard parameter that often surprises new users is the viscosity shift of 2-Methyl-5-hydroxypyridine solutions at sub-zero temperatures. When dissolved in THF at concentrations above 30% w/w, the solution viscosity increases sharply below -10°C, which can impede pumping and mixing in jacketed reactors. This is not a typical specification but is critical for processes involving cryogenic lithiation steps. We recommend pre-heating the solution to 0–5°C before transfer. Another edge case involves trace impurities affecting color: even 0.05% of an unknown oxidation byproduct can impart a pale yellow tint to the final API if not removed by charcoal treatment. Our Pharma Grade includes a dedicated purification step (recrystallization with activated carbon) to ensure a white crystalline appearance, which is often a visual quality requirement for pharmaceutical intermediates.
Frequently Asked Questions
What melting point depression indicators should I look for in 2-Methyl-5-hydroxypyridine?
A melting point below 165°C (by DSC) typically indicates the presence of impurities such as 2-methylpyridine or water. A broad melting range (>2°C) suggests poor crystallinity or polymorphic mixture. Always compare with the batch-specific COA; our Pharma Grade consistently shows a sharp endotherm at 166.5–167.5°C.
What is the optimal anti-solvent for downstream crystallization of APIs derived from 2-Methyl-5-hydroxypyridine?
For APIs where 2-Methyl-5-hydroxypyridine is a building block, water is often the anti-solvent of choice due to its high polarity and safety. However, for hydrophobic intermediates, n-heptane or cyclohexane can be used. The key is to add the anti-solvent at a controlled rate (0.5–1.0 L/min per 1000L reactor) to avoid oiling out. Our technical team can provide guidance based on your specific API.
Which COA parameters best predict filtration efficiency for 2-Methyl-5-hydroxypyridine?
Particle size distribution (D10, D50, D90) and crystal habit (observed by microscopy) are the most predictive. A narrow PSD with D90/D10 < 3 and plate-like crystals ensure low filtration resistance. Additionally, low water content (<0.1%) prevents agglomeration. Our COA includes PSD data upon request.
Sourcing and Technical Support
As a global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. offers reliable supply of 2-Methyl-5-hydroxypyridine with consistent quality and competitive bulk pricing. Our product serves as a direct drop-in replacement for other commercial sources, with identical technical parameters and polymorphic form. We support custom synthesis and can provide samples for evaluation. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.